Graft thrombosis (up to 3 months) · people with ESRD receiving haemodialysis through an arteriovenous graft
Warfarin showed no clear difference in graft thrombosis (up to 37 months) compared with placebo (low certainty).
1 finding from 1 review
Length of hospital stay · people with ESRD receiving haemodialysis through an arteriovenous graft
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Complications (up to 37 months) · people with ESRD receiving haemodialysis through an arteriovenous graft
1 finding from 1 review
Number of related surgical or radiological interventions · people with ESRD receiving haemodialysis through an arteriovenous graft
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
All‐cause death · patients with heart failure with sinus rhythm
Warfarin showed no clear difference in all‐cause death compared with placebo or no treatment (low certainty).
1 finding from 1 review
Stroke · patients with heart failure with sinus rhythm
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Major bleeding · patients with heart failure with sinus rhythm
Warfarin may leads to higher major bleeding eventsc compared with placebo or no treatment (low certainty).
1 finding from 1 review
Therapeutic INR INR TEST · patients with venous thromboembolism.
10 mg warfarin nomogram probably leads to higher therapeutic INR INR TEST compared with 5 mg warfarin nomogram (moderate certainty).
1 finding from 1 review
Recurrent venous thromboembolism · patients with venous thromboembolism.
10 mg warfarin nomogram showed no clear difference in recurrent venous thromboembolism sonography or lung scan or chest… compared with 5 mg warfarin nomogram (low certainty).
1 finding from 1 review
Major bleeding fall in hemoglobin of > 20 g/L or transfusion of 2 or more units of red cells · patients with venous thromboembolism.
10 mg warfarin nomogram showed no clear difference in major bleeding fall in hemoglobin of > 20 g/L or transfusion of 2 or… compared with 5 mg warfarin nomogram (moderate certainty).
1 finding from 1 review
Minor bleeding · patients with venous thromboembolism.
It is very uncertain whether 10 mg warfarin nomogram changes minor bleeding it is not major bleeding compared with 5 mg warfarin nomogram (very low certainty).
1 finding from 1 review
Duration of hospital stay (days) for 'rescue' therapy · patients with venous thromboembolism.
1 finding from 1 review
All‐cause mortality · patients with heart failure with sinus rhythm
Summary of findings: warfarin showed no clear difference in all‐cause mortality compared with aspirin (moderate certainty).
1 finding from 1 review
Non‐fatal cardiovascular events · patients with heart failure with sinus rhythm
Summary of findings: warfarin showed no clear difference in non‐fatal cardiovascular events (non‐fatal stroke, myocardial… compared with aspirin (moderate certainty).
1 finding from 1 review
Major bleeding · patients with heart failure with sinus rhythm
Summary of findings: warfarin probably leads to higher major bleeding events compared with aspirin (moderate certainty).
1 finding from 1 review
All‐cause mortality · patients with heart failure with sinus rhythm
Summary of findings: warfarin showed no clear difference in all‐cause mortality compared with clopidogrel (low certainty).
1 finding from 1 review
Non‐fatal cardiovascular events · patients with heart failure with sinus rhythm
Summary of findings: warfarin showed no clear difference in non‐fatal cardiovascular events (non‐fatal stroke, myocardial… compared with clopidogrel (low certainty).
1 finding from 1 review
Major bleeding · patients with heart failure with sinus rhythm
Summary of findings: warfarin may leads to higher major bleeding events compared with clopidogrel (low certainty).
1 finding from 1 review